NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!
Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.
Start Free »

ALGN | NASDAQ

$145.47 $1.46 | 1.01%
SIGNAL:Signal available — unlock to view |2026-08-18 |F&G 23 |RSI 38.9

Company Overview:

Market Cap: $10.33B
Trailing PE: 25.3x
FWD PE *: 12.3x
Payout Ratio (TTM): —
52-Week Range: $124.91 - $200.44

* Forward PE is based on street estimates.

10 Year ALGN Performance Metrics:

Total Return (with DRIP): 61.3% (4.89% CAGR)
Total Return (no DRIP): 61.3% (4.89% CAGR)
Share Price: 55.2% (4.49% CAGR)
Yield on Cost (with DRIP): —
Total Invested: $10,000
Total Value (with DRIP): $16,126
Total Return $ (with DRIP): $6,126
ALGN Total Return
1M 3M 6M YTD 1Y 3Y 5Y 10Y
ALGN Price Chart
1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

ALGN Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

ALGN - Revenue
ALGN Revenue CAGR:1Y: 4.32%2Y: 1.34%5Y: 0.88%10Y: 14.64%
ALGN - Earnings Per Share (EPS)
ALGN EPS CAGR:1Y: -12.21%2Y: 8.61%5Y: -9.66%10Y: 9.31%
ALGN - Net Income
ALGN Net Income CAGR:1Y: -13.09%2Y: 5.90%5Y: -11.52%10Y: 8.00%
ALGN - EBITDA
ALGN EBITDA CAGR:1Y: 26.85%2Y: 12.56%5Y: 0.20%10Y: 14.48%
ALGN - Free Cash Flow
ALGN Free Cash Flow CAGR:1Y: 2.05%2Y: 21.52%5Y: -4.06%10Y: 10.60%
ALGN - Free Cash Flow / Share
ALGN Free Cash Flow / Share CAGR:1Y: 47.46%2Y: 48.69%5Y: 5.04%10Y: 15.87%
ALGN - Operating Income
ALGN Operating Income CAGR:1Y: 18.21%2Y: 14.48%5Y: -6.44%10Y: 11.46%
ALGN - Gross Profit
ALGN Gross Profit CAGR:1Y: 6.96%2Y: 2.38%5Y: -0.03%10Y: 13.95%
ALGN - Shares Outstanding
ALGN Shares Outstanding CAGR:1Y: -1.48%2Y: -2.49%5Y: -2.13%10Y: -1.27%
ALGN - Share Buybacks
ALGN Share Buybacks CAGR:1Y: -30.31%2Y: -33.20%5Y: 0.00%10Y: 6.70%
ALGN - Stock-Based Comp
ALGN Stock-Based Comp CAGR:1Y: 0.00%2Y: -1.57%5Y: 9.57%10Y: 12.77%
ALGN - Expenses
ALGN Expenses CAGR:1Y: 21.73%2Y: -24.11%5Y: -24.35%10Y: 5.05%
ALGN - Revenue by Segment
ALGN Revenue CAGR:1Y: 4.32%2Y: 1.34%5Y: 0.88%10Y: 14.64%
ALGN - Revenue by Region
ALGN Revenue CAGR:1Y: 4.32%2Y: 1.34%5Y: 0.88%10Y: 14.64%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ALGN - REVENUE: Actual + Estimates
ALGN Actual Revenue CAGR:1Y: 4.32%2Y: 1.34%5Y: 0.88%10Y: 14.64%
ALGN - EPS: Actual + Estimates
ALGN Actual EPS CAGR:1Y: -12.21%2Y: 8.61%5Y: -9.66%10Y: 9.31%
ALGN - NET INCOME: Actual + Estimates
ALGN Actual Net Income CAGR:1Y: -13.09%2Y: 5.90%5Y: -11.52%10Y: 8.00%
ALGN - EBITDA: Actual + Estimates
ALGN Actual EBITDA CAGR:1Y: 26.85%2Y: 12.56%5Y: 0.20%10Y: 14.48%

Ratios, Profit Margins & Return on Capital:

ALGN - Net Profit Margin
ALGN Net Profit Margin CAGR:1Y: -16.73%2Y: 4.48%5Y: -12.30%10Y: -5.79%
ALGN - Gross Profit Margin
ALGN Gross Profit Margin CAGR:1Y: -6.86%2Y: -3.71%5Y: -2.79%10Y: -1.55%
ALGN - Price to Earnings
ALGN Price to Earnings CAGR:1Y: 1.47%2Y: -22.47%5Y: -14.31%10Y: -1.39%
ALGN - Price To Sales Ratio
ALGN Price To Sales Ratio CAGR:1Y: -15.91%2Y: -19.12%5Y: -24.90%10Y: -7.13%
ALGN - Return on Capital Employed
ALGN Return on Capital Employed CAGR:1Y: -29.16%2Y: -12.49%5Y: -17.76%10Y: -8.76%
ALGN - Return on Invested Capital
ALGN Return on Invested Capital CAGR:1Y: -28.15%2Y: -8.85%5Y: -19.20%10Y: -9.64%

Compare stocks side-by-side

Projected Future Returns & Dividends for ALGN

Based on past 10-year performance, here are ALGN growth metrics:

Share price CAGR of +4.49%
Dividend CAGR of +0%

Using ALGN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

ALGN (DRIP)ALGN - No DRIP
Current Price$145.47$145.47
Start Shares68.7468.74
Start Value$10,000$10,000
  
After 10 years:
Final Share Count68.7468.74
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$145.47$145.47
Total Dividends$0$0
Final Value$10,000$10,000

Estimated Future Value + Dividends - ALGN

NOTE: Above numbers are our estimate based on ALGN's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)

Company Info

Align Technology, Inc. (ALGN) had its IPO on 2001-01-30, and is traded on NASDAQ stock exchange.

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

ALGN website: https://www.aligntech.com


Get Full Access to All Reports with DRIPCalc PRO

Save 25% with annual plan (3 Months Free)
PRO
$171 ($14.25/mo) $102.60/yr ($8.55/mo)
7-day free trial
  • Unlimited Portfolio Tracker
  • Portfolio - Lots/Sales/Dividends
  • Portfolio Auto-DRIP
  • Buy/Sell Signals Dashboard
  • Stock Fundamentals
  • Compare Stocks Side-by-Side
  • Revenue & EPS Estimates
  • DCF Valuation Modeling
Try it free for 7 days
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo) $172.80/yr ($14.40/mo)
7-day free trial
  • Everything in Pro
  • YieldMax PNL Tracker
  • YieldMax NAV Erosion Alerts
  • YM ETFs Trend Signals
  • 9/21 EMA Trend Signals
  • Stocks Dashboard
Try it free for 7 days
You save $211.20 (55%)
ULTRA
$576 ($48/mo) $345.60/yr ($28.80/mo)
7-day free trial
  • Everything in Premium
  • 15min & 1hr Intraday Signals
  • Group & weekly ETF estimates
  • YouTuber Mode
  • Trades summary + CSV export
  • Priority data & support
Try it free for 7 days
You save $422.40 (55%)
Loading signals…

DCF Model — ALGN

Value from:
Pay up to today
—
vs current price $145.47
—
Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
YearFCFImplied price
Sensitivity — fair value: growth ↓ × target return →